Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphocytic Bronchiolitis”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Testing effectiveness (Phase 2)Study completedNCT04716075
What this trial is testing

Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)

Who this might be right for
Chronic Lymphocytic LeukemiaChronic Graft-versus-host-diseaseMantle Cell Lymphoma+2 more
Polish Lymphoma Research Group 29
Early research (Phase 1)Ended earlyNCT01663766
What this trial is testing

Phase I Study of Milatuzumab for Graft Versus Host Disease

Who this might be right for
GVHD (Acute or Chronic)Acute Myeloid or Lymphoblastic Leukemia (AML or ALL)Myelodysplastic Syndrome+4 more
Gilead Sciences 12
Not applicableUnknownNCT05692713
What this trial is testing

Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)

Who this might be right for
Chronic Graft-versus-Host-DiseaseAllogeneic Hematopoietic Stem Cell TransplantationLeukemia+2 more
University of British Columbia 320
Not applicableStudy completedNCT02164071
What this trial is testing

Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies

Who this might be right for
Myelodysplastic SyndromesLeukemia Myeloid AcuteMultiple Myeloma+1 more
Celgene 363
Testing effectiveness (Phase 2)Looking for participantsNCT06476132
What this trial is testing

Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

Who this might be right for
Lung Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 234
Large-scale testing (Phase 3)Looking for participantsNCT01804686
What this trial is testing

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMantle Cell Lymphoma+4 more
Janssen Research & Development, LLC 700
Post-approval studies (Phase 4)Study completedNCT01109160
What this trial is testing

Study of Azithromycin for Lymphocytic Bronchiolitis/Bronchitis After Lung Transplantation

Who this might be right for
Lymphocytic Bronchi(Oli)Tis Post-lung Transplantation
KU Leuven 15
Early research (Phase 1)Study completedNCT01680991
What this trial is testing

Obinutuzumab in Chinese Participants With CD20+ Malignant Disease

Who this might be right for
Lymphocytic Leukemia, Chronic, Diffuse Large B-cell Lymphoma, Follicular Lymphoma
Hoffmann-La Roche 48
Testing effectiveness (Phase 2)Study completedNCT00077922
What this trial is testing

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphocyticChronic
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00021749
What this trial is testing

Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaCLL
Genta Incorporated 40
Testing effectiveness (Phase 2)Study completedNCT01994382
What this trial is testing

Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL

Who this might be right for
Follicular Lymphoma (FL/Indolent NHL)Aggressive NHL (a NHL)Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)+2 more
Alexion Pharmaceuticals, Inc. 260
Post-approval studies (Phase 4)Study completedNCT01009619
What this trial is testing

Azithromycin in Bronchiolitis Obliterans Syndrome

Who this might be right for
Bronchiolitis Obliterans SyndromeGraft RejectionLymphocytic Bronchiolitis+1 more
KU Leuven 83
Early research (Phase 1)Ended earlyNCT03759184
What this trial is testing

Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia

Who this might be right for
LeukemiaLymphocyticChronic+1 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Study completedNCT00280241
What this trial is testing

Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
University of Pittsburgh 65
Large-scale testing (Phase 3)Study completedNCT01313689
What this trial is testing

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Leukaemia
Novartis Pharmaceuticals 122
Large-scale testing (Phase 3)Study completedNCT01578707
What this trial is testing

Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Relapsed or Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Pharmacyclics LLC. 391
Early research (Phase 1)Study completedNCT01149668
What this trial is testing

A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer

Who this might be right for
LymphomaNon-Hodgkin's LymphomaHodgkin Disease+3 more
Pharmacyclics LLC. 7
Not applicableStudy completedNCT03042676
What this trial is testing

Electronic Database for the Follow up of the ATG_FamilyStudy

Who this might be right for
GVHD, ChronicAcute LeukemiaStem Cell Transplant Complications
IRCCS Azienda Ospedaliero-Universitaria di Bologna 104
Testing effectiveness (Phase 2)UnknownNCT01240525
What this trial is testing

Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
University College, London 114
Testing effectiveness (Phase 2)Study completedNCT00431873
What this trial is testing

A Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Lymphocytic Leukemia, Chronic
Mirati Therapeutics Inc. 21
Next Page